Eosinophils in asthma

Chinese Medical Journal

Volumn 117, Issue 5, 2004, Pages 792-794

  Shi, Huan Zhong ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC PROTEIN; CORTICOSTEROID; INTERLEUKIN 5 ANTIBODY; PLACEBO; SCH 55700; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; BRONCHUS REACTIVITY; CELL INFILTRATION; CLINICAL TRIAL; EOSINOPHIL; HOST RESISTANCE; HUMAN; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION; MEDLINE; PATHOPHYSIOLOGY; PROVOCATION TEST;

ANTIGEN PRESENTATION; ASTHMA; EOSINOPHILS; HUMANS;

EID: 2942558828     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Butterworth AE, Vadas MA, Wassom DL, et al. Interactions between human eosinophils and schistosomula of schistosoma mansoni. II. The mechanism of irreversible eosinophil adherence. J Exp Med 1979;150:1456-1471.
2. Busse WW, Lemanske RF. Asthma. N Engl J Med 2001; 344:350-362.
3. Wenzel SE, Schwartz LB, Langmack EL, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999;160:1001-1008.
4. Douwes J, Gibson P, Pekkanen J, et al. Non-eosinophilic asthma: importance and possible mechanisms. Throax 2002; 57:643-648.
5. Shi HZ, Xiao CQ, Zhong D, et al. Effect of inhaled interleukin-5 on airway hyperreacitvity and eosinophilia in asthmatics. Am J Respir Critical Care Med 1998; 157:204-209.
6. Leckie MJ, ten Brinke A, Khan J, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinphils, airway hyperresponsiveness and the late asthmatic response. Lancet 2000;356:2144-2148.
7. Flood-Page PT, Menzies-Gow AN, Kay AB, et al. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003;167:199-204.
8. Kips JC, O'Connor BJ, Langley SJ, et al. Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. Am J Respir Crit Care Med 2003;167:1655-1659.
9. Rizzo CA, Yang R, Greenfeder S, et al. The IL-5 receptor on human bronchus selectively primes for hyperresponsiveness. J Allergy Clin Immunol 2002;109:404-409.
10. Wardlaw AJ, Brightling CE, Green R, et al. New insights into the relationship between airway inflammation and asthma. Clin Sci 2002;57:875-879.
11. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002;360:1715-1721.
12. Shi HZ, Xiao CQ. Antigen presentation of eosinophils and airway allergic inflammation. Chin J Intern Med (Chin) 2002;41:62-64.
13. Shi HZ, Humbles A, Gerard C, et al. Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest 2000;105:945-953.
14. Crowley M, Inaba K, Steinman RM. Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins. J Exp Med 1990;172:383-386.
15. Holt PG, Oliver J, Bilyk N, et al. Downregulation of the antigen presenting cell function (s) of pulmonary dendritic cells in vivo by resident alveolar macrophags. J Exp Med 1993;177:397-407.
16. Van Rooijen N. Antigen processing and presentation in vivo: the microenvironment as a crucial factor. Immunol Today 1990;11:436-439.
17. Chelen CJ, Fang Y, Freeman GJ, et al. Human alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface molecules. J Clin Invest 1995;95:1415-1421.